https://www.semanticscholar.org/topic/lifitegrast-50-MG-ML-Ophthalmic-Solution-%5BXiidra%5D/12370905
lifitegrast 50 MG/ML Ophthalmic Solution [Xiidra] | Semantic Scholar
50 mgophthalmic solutionlifitegrastmlxiidra
https://pmc.ncbi.nlm.nih.gov/articles/PMC6590901/
Six months' treatment with lifitegrast in patients with moderate-to-severe symptomatic dry eye: a...
To evaluate 6-month treatment benefits with lifitegrast ophthalmic solution 5% in symptomatic dry eye patients. Retrospective chart analysis. A retrospective...
https://www.prnewswire.co.uk/news-releases/us-fda-acknowledges-receipt-of-resubmission-of-shires-new-drug-application-for-lifitegrast-for-dry-eye-disease-in-adults-567715091.html
U.S. FDA Acknowledges Receipt of Resubmission of Shire's New Drug Application for Lifitegrast for...
/PRNewswire/ -- - New FDA action date of July 22, 2016 - Lifitegrast has the potential to be the only product approved in the U.S. in the past decade...
u s fda
https://www.mayoclinic.org/drugs-supplements/lifitegrast-ophthalmic-route/description/drg-20312356
Lifitegrast (ophthalmic route) - Side effects & dosage - Mayo Clinic
side effectslifitegrastophthalmicroutedosage
https://pmc.ncbi.nlm.nih.gov/articles/PMC5242036/
Lifitegrast: A novel drug for treatment of dry eye disease - PMC
Dry eye disease (DED) is an inflammatory disorder of ocular surfaces leading to severe disability, especially in the elderly age group. The mainstay of therapy...
dry eye diseaselifitegrastnoveldrug